CSIMarket


Abbott Laboratories  (ABT)
Other Ticker:  
 

Abbott Laboratories

ABT's Fundamental analysis






Looking into Abbott Laboratories growth rates, revenue grew by 28.71 % in IV. Quarter 2020 from the same quarter a year ago. Ranking at No. 584

Major Pharmaceutical Preparations industry recorded growth of revenues by 25.98 %

Abbott Laboratories's net income grew by 106.1 % in IV. Quarter 2020 year on year, above company average,

More on ABT's Growth


Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbott Laboratories PEG ratio is at 2.27 Company is currently trading with Price to Cash flow multiple of 74.74 in trailing twelve-month period.
Company
49.57
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.37.

Abbott Laboratories Price to Book Ratio is at 6.74 lower than Indusry Avg. of 1694.29. and higher than S&P 500 Avg. of 0.14

More on ABT's Valuation
 
 Total Debt (Millions $) 18,747
 Dividend TTM ($) 1.43 $
 Dividend Yield TTM (%) 1.15 %
 Revenue/Employee (TTM) $ 323,439
 Net Income/Employee (TTM) $ 42,009
 Receivable Turnover (TTM) 6.15
 Tangible Book Value (Per Share $) -3.09

Abbott Laboratories
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Abbott Laboratories PEG ratio is at 2.27 Company is currently trading with Price to Cash flow multiple of 74.74 in trailing twelve-month period.
Company
49.57
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 6.43.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.37.

Abbott Laboratories Price to Book Ratio is at 6.74 lower than Indusry Avg. of 1694.29. and higher than S&P 500 Avg. of 0.14

More on ABT's Valuation

  Market Capitalization (Millions $) 222,563
  Shares Outstanding (Millions) 1,791
  Employees 107,000
  Revenues (TTM) (Millions $) 34,608
  Net Income (TTM) (Millions $) 4,495
  Cash Flow (TTM) (Millions $) 2,978
  Capital Exp. (TTM) (Millions $) -2,177
  Total Debt (Millions $) 18,747
  Dividend TTM ($) 1.43 $
  Dividend Yield TTM (%) 1.15 %
  Revenue/Employee (TTM) $ 323,439
  Net Income/Employee(TTM) $ 42,009
  Receivable Turnover Ratio (TTM) 6.15
  Tangible Book Value (Per Share $) -3.09

  Market Capitalization (Millions $) 222,563
  Shares Outstanding (Millions) 1,791
  Employees 107,000
  Revenues (TTM) (Millions $) 34,608
  Net Income (TTM) (Millions $) 4,495
  Cash Flow (TTM) (Millions $) 2,978
  Capital Exp. (TTM) (Millions $) -2,177

ABT's Profitability Comparisons
Abbott Laboratories achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2020 to 22.73 % from 16.89 % in III. Quarter.

Abbott Laboratories net profit margin of 20.2 % is currently ranking no. 34 in Major Pharmaceutical Preparations industry, ranking no. 90 in Healthcare sector and number 894 in S&P 500.


Profitability by Segment
Established Pharmaceutical Products 18.42 %
Nutritionals 25.66 %
Vascular 35.57 %
Diagnostics 26.56 %



  Ratio
   Capital Ratio (MRQ) 1.72
  Total Debt to Equity (MRQ) 0.57
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.5
  Inventory Turnover Ratio (TTM) 3.01



Abbott Laboratories achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2020 to 22.73 % from 16.89 % in III. Quarter.

Abbott Laboratories net profit margin of 20.2 % is currently ranking no. 34 in Major Pharmaceutical Preparations industry, ranking no. 90 in Healthcare sector and number 894 in S&P 500.

More on ABT's Key Ratios





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

APCX's Profile

Stock Price

APCX's Financials

Business Description

Fundamentals

Charts & Quotes

APCX's News

Suppliers

APCX's Competitors

Customers & Markets

Economic Indicators

APCX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071